/
735V 17 2009practitioners There is a mention of demerits of theconju 735V 17 2009practitioners There is a mention of demerits of theconju

735V 17 2009practitioners There is a mention of demerits of theconju - PDF document

josephine
josephine . @josephine
Follow
342 views
Uploaded On 2022-09-22

735V 17 2009practitioners There is a mention of demerits of theconju - PPT Presentation

Consultant PediatrcianPedicare Ratu Roadrchsssidanarediffmailcom Alleviation of Pain Associated ID: 955360

vaccine efficacy trials field efficacy vaccine field trials phase study vaccines iap safety

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "735V 17 2009practitioners There is a men..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

735V 17, 2009practitioners. There is a mention of demerits of theconjugate Vi vaccine marketed in India in the IAPTypically any new vaccine (or for that matter anynew drug) has to undergo phase 1 (early safety anddosing study), phase 2 (safety, dosing andimmunogenicity study) and phase 3 (field efficacydo efficacy trials and can be licensed provided itwill assume and extrapolate similar efficacy for theis called bridging studies)(3). The new brand has toHowever if the serological correlates ofchoice but to conduct field efficacy trials to provevaccines for which huge and expensive field efficacyunconjugated Vi vaccine, oral Ty21a vaccine or thereason why for each of the

se vaccines field efficacytrials have been conducted and reported(5). This isconducting field efficacy trails with their owncandidate conjugate Vi vaccine(2). drnitinshah@hotmail.com.1.Singhal T, Amdekar Y, Agarwal R. IAP Guidebook2.Clemens J. Translational research to generate3.Jódar L, Butler J, Carlone G, Dagan R, Goldblatt D,4.Cherry JD. Comparative efficacy of acellularpertussis vaccines: an analysis of recent trials.5.Engels EA, Matthew EF, Joseph L, Michael LB.others prescribe Thrombophob ointment application,besides paracetamol. What is the stand of IAP on this Consultant Pediatrcian,Pedicare, Ratu Road,rch_sssidana@rediffmail.com. Alleviation of Pain Associate